Genetics of Rolandic Epilepsy
NCT00282854 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2023-06-28
Summary
The purpose of this study is to find the genes that cause Rolandic epilepsy and its related traits.
Conditions
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
collaborator NIH - lead OTHER
Principal Investigators
-
Deb K. Pal, MD, PhD · Associate Research Scientist, Mailman School of Public Health, Columbia University Medical Center
Eligibility
- Min Age
- 3 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-01-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- United States
Study Locations
More Related Trials
-
Biology of Juvenile Myoclonic Epilepsy
NCT03400371 ·Status: RECRUITING
-
Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
NCT05374824 ·Status: RECRUITING
-
Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies
NCT02968966 ·Status: WITHDRAWN ·Phase: PHASE2
-
Genetic Diagnosis and Personalized Medicine for Patients With Epilepsy
NCT06321822 ·Status: RECRUITING ·Phase: NA
-
Genotype, Phenotype, and Disease Progression of Developmental Epileptic Encephalopathy With Onset Before 2 Years of Age
NCT06278428 ·Status: RECRUITING
-
PRX-00023 Therapy in Localization-Related Epilepsy
NCT01281956 ·Status: TERMINATED ·Phase: PHASE2
-
Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis
NCT06701084 ·Status: RECRUITING ·Phase: NA
-
Novel Network Analysis of Intracranial Stereoelectroencephalography
NCT03916848 ·Status: UNKNOWN ·Phase: NA
-
Study of Predictors of Response to Anti Epilepsy in Epilepsy
NCT02883712 ·Status: TERMINATED
-
A Pharmacogenomic Exploration of Lacosamide Response
NCT01399528 ·Status: UNKNOWN
-
Evaluation and Treatment of Patients With Epilepsy
NCT00013845 ·Status: TERMINATED
-
A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy
NCT03934268 ·Status: UNKNOWN
-
Clobazam in Subjects With Lennox-Gastaut Syndrome
NCT00162981 ·Status: COMPLETED ·Phase: PHASE2
-
Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects
NCT01370486 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome
NCT00236756 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
NCT02834793 ·Status: TERMINATED ·Phase: PHASE3
-
Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
NCT02655198 ·Status: UNKNOWN ·Phase: PHASE2
-
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
NCT00210522 ·Status: COMPLETED ·Phase: PHASE2
-
Risk Factors and Etiologies of Epilepsy in Urban and Rural Rwanda
NCT05698537 ·Status: COMPLETED
-
Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies
NCT02890641 ·Status: RECRUITING
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
Association of Brain Derived Neurotrophic Factor (BDNF) rs6265 Gene Polymorphism With Susceptibility to Epilepsy
NCT05096871 ·Status: UNKNOWN
-
Investigating Epilepsy: Screening and Evaluation
NCT03478852 ·Status: RECRUITING
-
Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type
NCT00639119 ·Status: UNKNOWN ·Phase: PHASE2
-
Surgery as a Treatment for Medically Intractable Epilepsy
NCT01273129 ·Status: RECRUITING